Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening and brief intervention enter their 5th decade.

Richard Saitz1

  • 1Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Boston Medical Center, 91 E Concord Street, Boston, MA 02118-2644, USA. rsaitz@bu.edu

Substance Abuse
|December 14, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impacts of personal or family COVID-19 infection on health-related quality of life among patients with opioid use disorder.

Journal of substance use·2026
Same author

"The Sky Didn't Fall": Patient and Clinician Experiences With Increased Buprenorphine Prescription Lengths During Pandemic-related Telehealth Expansion.

Journal of addiction medicine·2026
Same author

Associations between COVID impact domains and time to buprenorphine treatment disengagement.

The American journal of drug and alcohol abuse·2025
Same author

Patient and Provider Perspectives on the Elimination of Urine Drug Testing in Office-Based Addiction Treatment.

Substance use & addiction journal·2025
Same author

Pain and alcohol consumption among people living with HIV: examining the moderating roles of depression and social support.

Alcohol (Fayetteville, N.Y.)·2025
Same author

Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative study.

Addiction science & clinical practice·2025
Same journal

Association of MOUD ECHO Participation on Expansion of Buprenorphine Prescribing in Rural Primary Care.

Substance abuse·2023
Same journal

A Pragmatic, Person-Centered View of Cannabis in the United States: Pursuing Care That Transcends Beliefs.

Substance abuse·2023
Same journal

Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy.

Substance abuse·2023
Same journal

Treatment Initiation, Substance Use Trajectories, and the Social Determinants of Health in Persons Living With HIV Seeking Medication for Opioid Use Disorder.

Substance abuse·2023
Same journal

Advancing Proficiencies for Health Professionals in the Treatment of Tobacco Use Among Marginalized Communities: Development of a Competency-Based Curriculum and Virtual Workshop.

Substance abuse·2023
Same journal

Care Practices of Mental Health Clinical Pharmacist Practitioners Within an Interdisciplinary Primary Care Model for Patients With Substance Use Disorders.

Substance abuse·2023
See all related articles

Screening and brief intervention (SBI) shows efficacy in reducing alcohol consumption for primary care patients. Further research is needed to optimize drug screening and real-world implementation of SBI.

Area of Science:

  • Addiction Medicine
  • Public Health
  • Behavioral Science

Background:

  • Screening and brief intervention (SBI) for unhealthy alcohol use has been studied for 40 years and is increasingly adopted.
  • Despite widespread dissemination, significant knowledge gaps persist regarding SBI's application and effectiveness.

Purpose of the Study:

  • To address unanswered questions and review the current state of knowledge on alcohol and drug screening and brief intervention (SBI).
  • To explore various facets of SBI including cost-effectiveness, patient preferences, clinical education, quality measures, and methodological challenges.

Main Methods:

  • This special issue synthesizes findings from multiple studies examining different aspects of SBI.
  • Includes review of evidence on efficacy, effectiveness in real-world settings, and predictors of behavior change.

Related Experiment Videos

Main Results:

  • The strongest evidence supports SBI's efficacy in reducing alcohol consumption among primary care patients with non-dependent unhealthy use.
  • Efficacy for drug use, effectiveness in diverse settings, and integration with other health behaviors require further investigation.

Conclusions:

  • SBI is a valuable tool for addressing unhealthy alcohol use in primary care.
  • Further research is crucial to refine drug screening tools, enhance real-world effectiveness, and optimize the dissemination of SBI strategies.